×
About 1,918 results

ALLMedicine™ Pediatric Hematology Center

Research & Reviews  881 results

Creating a cancer genomics curriculum for pediatric hematology-oncology fellows: A nati...
https://doi.org/10.1002/cam4.3787
Cancer Medicine; Murray AK, McGee RB et. al.

Feb 24th, 2021 - With the advent of next generation sequencing, tumor and germline genomic testing are increasingly being used in the management of pediatric cancer patients. Despite this increase in testing, many pediatric hematology-oncology (PHO) providers are ...

Clinicopathologic Features of Childhood Rhabdomyosarcoma and Treatment Outcomes in Ibad...
https://doi.org/10.1097/MPH.0000000000002093
Journal of Pediatric Hematology/oncology; Brown BJ, Ogun GO et. al.

Feb 24th, 2021 - The objectives of this study were to describe the clinicopathologic features and treatment outcomes of childhood rhabdomyosarcoma in a resource-constrained setting. All cases of childhood rhabdomyosarcoma seen over a 10-year period (July 2006 to J...

Clinical utility of complex assessment with evoked potentials in acute lymphoblastic le...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876796
BMC Cancer; Kroczka S, Stepien K et. al.

Feb 11th, 2021 - One of the greatest success of pediatric hematology is a prominent improvement of survival in acute lymphoblastic leukemia (ALL). Therefore, special attention needs to be paid to long-term side effects of the treatment such as neurotoxicity. One o...

Active learning for fellows: The hematopathology "unknown case".
https://doi.org/10.1002/pbc.28895
Pediatric Blood & Cancer; Aziz-Bose R, Wertheim G et. al.

Jan 23rd, 2021 - The pediatric hematology/oncology fellowship program at the Children's Hospital of Philadelphia set out to create a case-based learning curriculum for common hematologic malignancies that would apply principles of adult learning theory and improve...

see more →

Guidelines  15 results

Japan society of clinical oncology/Japanese society of medical oncology-led clinical re...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046581
International Journal of Clinical Oncology; Naito Y, Mishima S et. al.

Jan 24th, 2020 - The development of novel antitumor agents and accompanying biomarkers has improved survival across several tumor types. Previously, we published provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA...

APHON/ASPHO Policy Statement for the Transition of Patients With Sickle Cell Disease Fr...
https://doi.org/10.1177/1043454215591954
Journal of Pediatric Oncology Nursing : Official Journal ... Bryant R, Porter JS et. al.

Oct 15th, 2015 - With advances in medical care, the majority of children with sickle cell disease are surviving to adulthood. Patients, families, and providers now face the need for this growing population to move from pediatric- to adult-focused care. In order to...

Recommendations for the use of long-term central venous catheter (CVC) in children with...
https://doi.org/10.1007/s00277-015-2481-1
Annals of Hematology; Giordano P, Saracco P et. al.

Aug 24th, 2015 - Central venous catheters (CVC), used for the management of children with hemato-oncological disorders, are burdened by a significant incidence of mechanical, infective, or thrombotic complications. These complications favor an increasing risk in p...

Evidence-Based Management of Sickle Cell Disease: Expert Panel Report, 2014
https://www.nhlbi.nih.gov/health-topics/evidence-based-management-sickle-cell-disease
NHLBI

Aug 31st, 2014 - These guidelines were developed by an expert panel composed of health care professionals with expertise in family medicine, general internal medicine, adult and pediatric hematology, psychiatry, transfusion medicine, obstetrics and gynecology, eme.

Fertility Preservation for Pediatric and Adolescent Young Adult (AYA) Cancer Patients
http://aphon.org/UPLOADS/Education/pp4.pdf
Lisa Bashore

Jul 31st, 2014 - Pediatric hematology/oncology nurses are an important source of information for patients and families regarding topics important to their quality of life, such as fertility preservation. It is APHON’s position that discussions regarding fertility.

see more →

Clinicaltrials.gov  971 results

Creating a cancer genomics curriculum for pediatric hematology-oncology fellows: A nati...
https://doi.org/10.1002/cam4.3787
Cancer Medicine; Murray AK, McGee RB et. al.

Feb 24th, 2021 - With the advent of next generation sequencing, tumor and germline genomic testing are increasingly being used in the management of pediatric cancer patients. Despite this increase in testing, many pediatric hematology-oncology (PHO) providers are ...

Clinicopathologic Features of Childhood Rhabdomyosarcoma and Treatment Outcomes in Ibad...
https://doi.org/10.1097/MPH.0000000000002093
Journal of Pediatric Hematology/oncology; Brown BJ, Ogun GO et. al.

Feb 24th, 2021 - The objectives of this study were to describe the clinicopathologic features and treatment outcomes of childhood rhabdomyosarcoma in a resource-constrained setting. All cases of childhood rhabdomyosarcoma seen over a 10-year period (July 2006 to J...

Clinical utility of complex assessment with evoked potentials in acute lymphoblastic le...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876796
BMC Cancer; Kroczka S, Stepien K et. al.

Feb 11th, 2021 - One of the greatest success of pediatric hematology is a prominent improvement of survival in acute lymphoblastic leukemia (ALL). Therefore, special attention needs to be paid to long-term side effects of the treatment such as neurotoxicity. One o...

Active learning for fellows: The hematopathology "unknown case".
https://doi.org/10.1002/pbc.28895
Pediatric Blood & Cancer; Aziz-Bose R, Wertheim G et. al.

Jan 23rd, 2021 - The pediatric hematology/oncology fellowship program at the Children's Hospital of Philadelphia set out to create a case-based learning curriculum for common hematologic malignancies that would apply principles of adult learning theory and improve...

see more →

News  49 results

Choosing Wisely: 5 Recommendations on Testing to Avoid in Pediatric Hematology
https://www.staging.medscape.com/viewarticle/922471

Dec 10th, 2019 - ORLANDO, Florida — There's a new Choosing Wisely list in hematology focused specifically on children, with five tests or procedures that experts advise should be avoided, with some exceptions. The list, which was produced by an expert panel with r...

Choosing Wisely: 5 Recommendations on Testing to Avoid in Pediatric Hematology
https://www.medscape.com/viewarticle/922471

Dec 10th, 2019 - ORLANDO, Florida — There's a new Choosing Wisely list in hematology focused specifically on children, with five tests or procedures that experts advise should be avoided, with some exceptions. The list, which was produced by an expert panel with r...

Think twice: Choosing Wisely recommendations on testing to avoid in pediatric hematology
https://www.mdedge.com/hematology-oncology/article/213955/pediatrics/think-twice-choosing-wisely-recommendations-testing/page/0/1?channel=306

Dec 10th, 2019 - Previous studies on the platelet transfusions in patients with hematologic malignancies have shown that 10,000/mcL is the appropriate threshold, with no difference in bleeding above that number and increased bleeding below it, Dr. Bercovitz said.

Master trial seeks to aid drug development for pediatric AML
https://www.mdedge.com/hematology-oncology/article/200740/aml/master-trial-seeks-aid-drug-development-pediatric-aml?channel=181
Jennifer Smith

May 12th, 2019 - NEW ORLEANS – Researchers are organizing a master trial in an attempt to improve the treatment of pediatric acute myeloid leukemia (AML). The Pediatric Acute Leukemia (PedAL) trial is an effort to collect data on all pediatric AML patients.

Researchers to be honored at ASPHO
https://www.mdedge.com/hematology-oncology/article/199372/business-medicine/researchers-be-honored-aspho?channel=61642
Jennifer Smith

Apr 22nd, 2019 - Several hematology and oncology researchers will receive awards at the 2019 conference of the American Society of Pediatric Hematology/Oncology (ASPHO), which takes place May 1-4. Dr.

see more →

Patient Education  2 results see all →